Mebufotenin, Mebufotenin, Inhalation vapour, liquid, Mebufotenin
GH001-TRD-201
Phase 2 small_molecule active
Quick answer
Mebufotenin, Mebufotenin, Inhalation vapour, liquid, Mebufotenin for Treatment-resistant depression (TRD) is a Phase 2 program (small_molecule) at Elan Pharma International with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Elan Pharma International
- Indication
- Treatment-resistant depression (TRD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active